Treatment of Pulmonary disease conditions

Details for Australian Patent Application No. 2012201934 (hide)

Owner CSL Limited

Inventors Crump, David Eric; Nash, Andrew Donald

Agent Davies Collison Cave

Pub. Number AU-A-2012201934

Parent 2007283463

Filing date 3 April 2012

Wipo publication date 26 April 2012

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

19 April 2012 Complete Application Filed

26 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201934

26 April 2012 Corrigenda

  Complete Applications Filed - Name Index Under the name CSL Limited, Application No. 2012201934, under INID (54) correct the title to read Treatment of Pulmonary disease conditions

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201935-Portable Cleaner with Axle Mount

2012201933-Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer